Literature DB >> 24994016

[Anesthesia in a patient after endoscopic lung volume reduction. First anesthesiological experiences with implanted endobronchial valves].

P Hilbert1, K-P Litwinenko, B Niemann, K zur Nieden.   

Abstract

Chronic obstructive pulmonary disease (COPD) is a disease with a high incidence and extensive comorbidities that make COPD a key challenge for anesthesiologists. A new treatment strategy, such as endoscopic lung volume reduction (ELVR) with implantation of endobronchial valves is a rapidly developing area which is still unknown to many anesthesiologists. This article therefore describes first experiences in a patient with five endobronchial valves in the right upper lobe who needed urgent surgery due to lumbar disc herniation with neurological impairment. After preoperative evaluation of the patient's condition, the use of bronchodilating volatile anesthetics and adjusting the ventilatory settings with long expiration times and low peak pressure in a pressure controlled mode seems favorable in these patients. Intraoperatively, the patient should be assessed with modern physiological monitoring tools to titrate the administration of anesthetic agents, opioids and myorelaxant drugs. In conclusion the care of patients with implanted endobronchial valves after ELVR does not differ from COPD patients without ELVR. A close cooperation between surgeons, anesthesiologists and internists is mandatory in the care of these patients.

Entities:  

Mesh:

Year:  2014        PMID: 24994016     DOI: 10.1007/s00101-014-2350-7

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  12 in total

Review 1.  Mechanisms of cardioprotection by volatile anesthetics.

Authors:  Katsuya Tanaka; Lynda M Ludwig; Judy R Kersten; Paul S Pagel; David C Warltier
Journal:  Anesthesiology       Date:  2004-03       Impact factor: 7.892

Review 2.  [Bronchoscopic lung volume reduction (BLVR) in advanced pulmonary emphysema: dreams of the future or much ado about nothing?].

Authors:  F Stanzel
Journal:  Pneumologie       Date:  2011-11-23

3.  [AnaConDa as last resort treatment. Case report of a chronic obstructive pulmonary disease].

Authors:  E A Nickel; I Benken; U Bartels; W G Voelckel; M Quintel
Journal:  Anaesthesist       Date:  2007-06       Impact factor: 1.041

Review 4.  Lung volume reduction for advanced emphysema: surgical and bronchoscopic approaches.

Authors:  Sherry L Tidwell; Elizabeth Westfall; Mark T Dransfield
Journal:  South Med J       Date:  2012-01       Impact factor: 0.954

Review 5.  Current status of bronchoscopic lung volume reduction with endobronchial valves.

Authors:  Pallav L Shah; Felix J F Herth
Journal:  Thorax       Date:  2013-09-05       Impact factor: 9.139

6.  [The effect of halothane, enflurane and isoflurane on resistance and compliance in patients with asthma or chronic obstructive lung diseases].

Authors:  T Pasch; H D Kamp; H Petermann
Journal:  Anaesthesist       Date:  1991-02       Impact factor: 1.041

7.  Absence of bronchodilation during desflurane anesthesia: a comparison to sevoflurane and thiopental.

Authors:  M J Goff; S R Arain; D J Ficke; T D Uhrich; T J Ebert
Journal:  Anesthesiology       Date:  2000-08       Impact factor: 7.892

8.  GOLD classifications and mortality in chronic obstructive pulmonary disease: the HUNT Study, Norway.

Authors:  Linda Leivseth; Ben Michael Brumpton; Tom Ivar Lund Nilsen; Xiao-Mei Mai; Roar Johnsen; Arnulf Langhammer
Journal:  Thorax       Date:  2013-04-23       Impact factor: 9.139

Review 9.  Chronic obstructive pulmonary disease (COPD) evidentiary framework.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2012-03-01

Review 10.  Perioperative medical management of patients with COPD.

Authors:  Marc Licker; Alexandre Schweizer; Christoph Ellenberger; Jean-Marie Tschopp; John Diaper; François Clergue
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.